These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 34302575)

  • 1. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis.
    Lian H; Cui L; Yang Y; Wei A; Cheng H; Li N; Zhang L; Ma H; Zhao X; Wang T; Li Z; Zhang R
    Pituitary; 2022 Feb; 25(1):108-115. PubMed ID: 34302575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central diabetes insipidus as a very late relapse limited to the pituitary stalk in Langerhans cell histiocytosis.
    Nakagawa S; Shinkoda Y; Hazeki D; Imamura M; Okamoto Y; Kawakami K; Kawano Y
    J Pediatr Endocrinol Metab; 2016 Jul; 29(7):873-8. PubMed ID: 27089406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report.
    Zhou W; Rao J; Li C
    BMC Endocr Disord; 2019 Dec; 19(1):143. PubMed ID: 31856773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
    DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [MR-documented remission of pituitary stalk infiltration in patients with Langerhans cell histiocytosis following treatment with 2-chlorodeoxyadenosine].
    Vanícek J; Adam Z; Balsíková K; Krejcí M; Pour L; Szturz P; Zahradová L; Hájek R; Koukalová R; Rehák Z; Král Z; Mayer J
    Vnitr Lek; 2011 Oct; 57(10):871-5. PubMed ID: 22097697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
    Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
    BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
    Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
    Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
    [No Abstract]   [Full Text] [Related]  

  • 8. Central diabetes insipidus in pediatric patients with Langerhans cell histiocytosis: Results from the JLSG-96/02 studies.
    Sakamoto K; Morimoto A; Shioda Y; Imamura T; Imashuku S;
    Pediatr Blood Cancer; 2019 Jan; 66(1):e27454. PubMed ID: 30207064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary Stalk Thickening: Causes and Consequences. The Children's Memorial Health Institute Experience and Literature Review.
    Moszczyńska E; Kunecka K; Baszyńska-Wilk M; Perek-Polnik M; Majak D; Grajkowska W
    Front Endocrinol (Lausanne); 2022; 13():868558. PubMed ID: 35669693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central diabetes insipidus as the inaugural manifestation of Langerhans cell histiocytosis: natural history and medical evaluation of 26 children and adolescents.
    Marchand I; Barkaoui MA; Garel C; Polak M; Donadieu J;
    J Clin Endocrinol Metab; 2011 Sep; 96(9):E1352-60. PubMed ID: 21752883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central diabetes insipidus: Is it Langerhans cell histiocytosis of the pituitary stalk? A diagnostic pitfall.
    Prosch H; Grois N; Bökkerink J; Prayer D; Leuschner I; Minkov M; Gadner H
    Pediatr Blood Cancer; 2006 Mar; 46(3):363-6. PubMed ID: 15942956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Central diabetes insipidus: beware of Langerhans cell histiocytosis!
    Brys ADH; Vermeersch S; Forsyth R; Velkeniers B; Bravenboer B
    Neth J Med; 2018 Dec; 76(10):445-449. PubMed ID: 30569891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary stalk thickening in patients under 18 years of age - the most common causes and diagnostic procedures.
    Moszczyńska E; Baszyńska-Wilk M; Zasada K; Majak D; Szaniawska M; Szalecki M
    Pediatr Endocrinol Diabetes Metab; 2022; 28(3):213-227. PubMed ID: 35620922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes and prognostic risk factors of Langerhans cell histiocytosis in children: Results from the BCH-LCH 2014 protocol study.
    Cui L; Wang CJ; Lian HY; Zhang L; Ma HH; Wang D; Chen FF; Zhang Q; Yang Y; Wei A; Huang XT; Zhu T; Wang TY; Li ZG; Zhang R
    Am J Hematol; 2023 Apr; 98(4):598-607. PubMed ID: 36594188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine Outcomes In Central Diabetes Insipidus: the Predictive Value of Neuroimaging "Mismatch Pattern".
    Bianco D; Napoli F; Morana G; Pistorio A; Allegri AEM; Fava D; Schiavone M; Thiabat HF; Crocco M; Camia T; Lezzi M; Calandrino A; Tortora D; Severino M; Patti G; Ibba A; Rossi A; Di Iorgi N; Maghnie M
    J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32797230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated hypothalamic-pituitary langerhans' cell histiocytosis in female adult: A case report.
    Tan H; Yu K; Yu Y; An Z; Li J
    Medicine (Baltimore); 2019 Jan; 98(2):e13853. PubMed ID: 30633157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis.
    Prosch H; Grois N; Prayer D; Waldhauser F; Steiner M; Minkov M; Gadner H
    Pediatr Blood Cancer; 2004 Oct; 43(5):594-9. PubMed ID: 15382278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative central nervous system Langerhans cell histiocytosis and coincident hydrocephalus treated with vincristine/cytosine arabinoside.
    Allen CE; Flores R; Rauch R; Dauser R; Murray JC; Puccetti D; Hsu DA; Sondel P; Hetherington M; Goldman S; McClain KL
    Pediatr Blood Cancer; 2010 Mar; 54(3):416-23. PubMed ID: 19908293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ddPCR Analysis Reveals BRAF V600E Mutations Are Infrequent in Isolated Pituitary Langerhans Cell Histiocytosis Patients.
    Nellan A; Bodlak A; Mirsky DM; Mulcahy Levy J; Garrington TP; Foreman NK; Gilani A; Hayashi M
    J Neuropathol Exp Neurol; 2020 Dec; 79(12):1313-1319. PubMed ID: 32930721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infantile-Onset Isolated Neurohypophyseal Langerhans Cell Histiocytosis with Central Diabetes Insipidus: A Case Report.
    Tani M; Hiroshima S; Sato H; Sawano K; Ogawa Y; Imamura M; Oishi M; Nagasaki K
    Children (Basel); 2022 May; 9(5):. PubMed ID: 35626895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.